Kazumasa Hasegawa

Novel Potent Orally Active Selective VEGFR-2 Tyrosine Kinase Inhibitors:  Synthesis, Structure−Activity Relationships, and Antitumor Activities of <i>N</i>-Phenyl-<i>N</i>‘-{4-(4-quinolyloxy)phenyl}ureas

Kazuo Kubo, Toshiyuki Shimizu, Shin-ichi Ohyama et al. · Journal of Medicinal Chemistry · 2005 · 143 citations · Full text

Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma

Cécile Rouleau, Maritza Curiel, William Weber et al. · Clinical Cancer Research · 2008 · 116 citations · Full text

Complement Activation Plays a Key Role in Antibody-Induced Infusion Toxicity in Monkeys and Rats

Tomonori Tawara, Kazumasa Hasegawa, Yusuke Sugiura et al. · The Journal of Immunology · 2008 · 56 citations · Full text

Key Role, Immunotoxicology, Humoral Response +20

Preparation, characterization and taste-masking properties of polyvinylacetal diethylaminoacetate microspheres containing trimebutine

Yoshimi Hashimoto, Masami Tanaka, Hideyuki Kishimoto et al. · Journal of Pharmacy and Pharmacology · 2002 · 53 citations · Full text

Establishment of a novel monoclonal antibody against LGR5

Yuka Sasaki, Hiromichi Kosaka, Katsuaki Usami et al. · Biochemical and Biophysical Research Communications · 2010 · 22 citations

Autoimmune Disease, Medicine, Immunology +7